Lung cancer combo trial halted early
Disease control
Terminated
This early-stage trial tested a new drug called bemcentinib added to standard chemotherapy and immunotherapy for people with advanced non-squamous lung cancer. The study aimed to check safety and find the right dose, but it was terminated early. Only 26 people took part, so we ca…
Phase: PHASE1, PHASE2 • Sponsor: BerGenBio ASA • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC